This questions the suitability of vWF levels as a marker for endothelial dysfunction at an early disease state and indicates that, at the early onset of hypertension, vWF is not a target of LC n-3 PUFAs to mediate their cardioprotective effects at the concentration and duration used in this study. This evidence concerns the gene VWF and hypertensive disorder.